Search

Your search keyword '"Carey Kimmelstiel"' showing total 153 results

Search Constraints

Start Over You searched for: Author "Carey Kimmelstiel" Remove constraint Author: "Carey Kimmelstiel"
153 results on '"Carey Kimmelstiel"'

Search Results

1. Comorbidity Burden and Adverse Outcomes After Transcatheter Aortic Valve Replacement

5. Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation

6. Early Experience with the HeartMate Percutaneous Heart Pump from the SHIELD II Trial

7. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy

8. Do patients with non-viable myocardium from ischemic cardiomyopathy benefit from revascularization? A systematic review and meta-analysis

10. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary

11. PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization

12. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

13. Incidence and clinical outcomes of stroke in <scp>ST</scp> ‐elevation myocardial infarction and cardiogenic shock

15. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

19. Alcohol Septal Ablation

21. TCT-34 Reduction of Infarct Size in Anterior ST-Segment Elevation Myocardial Infarction (STEMI) With LAD Occlusion and LV Unloading Using a Micro-axial Pump for 30 Minutes Before PCI: Per-Protocol Analysis of the STEMI Door to Unload (DTU) Pilot Study

22. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

23. Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel

24. Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment–Elevation Myocardial Infarction

26. Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice

27. Transcatheter Tricuspid Valve Intervention in Right Ventricular Dysfunction and Pulmonary Hypertension

28. Echocardiographic Assessment of Left Ventricular Assist Device Outflow Velocity During Percutaneous Decommissioning

29. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary

30. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

31. Incidence and Clinical-Outcomes of Bleeding Complications and Acute Limb Ischemia In STEMI and Cardiogenic Shock

32. Combined alcohol septal ablation and transcatheter aortic valve replacement: Drunk and playing with fire

33. Noncanonical Matrix Metalloprotease 1–Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis

34. Cardiology Procedures : A Clinical Primer

35. Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX

36. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

37. Morphine in primary percutaneous coronary intervention—No pain, questionable gain

38. Fixed, high‐volume alcohol dose for septal ablation: High risk with no benefit

39. Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes

40. First‐in‐human experience with occlusion of the superior vena cava to reduce cardiac filling pressures in congestive heart failure

41. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

42. COMORBIDITY BURDEN AND ADVERSE OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT

43. IMPROVED PHARMACOLOGIC PROFILE OF A NOVEL, LIQUID ASPIRIN FORMULATION COMPARED WITH ENTERIC COATED ASPIRIN-A POOLED, PATIENT LEVEL ANALYSIS OF TWO RANDOMIZED CROSSOVER STUDIES

44. IMPACT OF WEIGHT ON THE ANTIPLATELET EFFECTS OF ASPIRIN-RESULTS OF A POOLED ANALYSIS OF TWO RANDOMIZED CROSSOVER STUDIES COMPARING A LIQUID ASPIRIN FORMULATION WITH ENTERIC COATED ASPIRIN

45. Real life experience with bioresorbable-polymer everolimus-eluting stents. Is this an answer in search of a question?

46. Heparin or bivalirudin for non-primary PCI: Beware of neat and simple answers…

47. Striking a balance between quality and cost in PCI

48. TCT-825 A Novel Post-Closure Method for Hemostatic Removal of the Impella CP Pump Among Patients With Cardiogenic Shock

49. Cardiology Procedures : A Clinical Primer

Catalog

Books, media, physical & digital resources